Some providers featured on this site may compensate us. This may affect the order and placement of listings but does not influence our editorial ratings or reviews.
Treatments Hub

Verified prices

All verified prices
Guide7 min read

Is HealthRx Legit? The $39 First-Month GLP-1, Checked

HealthRx sells semaglutide at $125/month after a $39 first month. We verified its LegitScript certification, clinician gate, and where the risk sits.

Updated September 15, 2026

Medically reviewed on

How we review

Key takeaways

  • HealthRx is LegitScript-certified (certificate 50087439, checkable in the public registry), every request is reviewed by an independent US-licensed clinician in your state, and fulfillment runs through licensed 503A pharmacies.
  • The assessment is free, takes about two minutes and requires no payment - a clinician reviews your file before any charge.
  • The monthly plan is $39 for the first month, then $125/month for compounded semaglutide or $199/month for tirzepatide until canceled (read Nov 18, 2026), with the consult, free overnight cold-chain shipping, dose adjustments at no extra cost and ongoing check-ins; longer plans cost less per month, but the tiers are not shown.
  • The real risk is fit, not fraud: the lower rates on longer plans are not shown on its pages, so the cheapest tier cannot be priced, and a newer brand has a thin public review record.

The right question about a $39 first month

The short answerYes. HealthRx is LegitScript-certified (certificate 50087439, checkable in the public registry), every request is reviewed by an independent US-licensed clinician in your state before any charge, and fulfilment runs through licensed 503A pharmacies. The monthly plan is $39 for the first month, then $125 a month for compounded semaglutide, with the consult, overnight cold-chain shipping and dose adjustments included; tirzepatide is $199 a month after the first month. The real risk is fit, not fraud: longer plans cost less per month, but the tiers are not shown on its pages.

A low first month sharpens the usual legitimacy question. It isn't just "will they send real medication" - it's "what do I pay from month two, and what would a longer plan cost?" That's the actual bet, so this piece audits it like one: verify the operation, then price the risk.

Verification first. HealthRx is LegitScript-certified - certificate 50087439, checkable in LegitScript's public registry - the same third-party healthcare-merchant vetting the major players carry. Every request is reviewed by an independent US-licensed clinician in your state, and their own materials state it plainly: approval is never automatic. Fulfillment runs through licensed 503A compounding pharmacies, shipped overnight, cold-chain, lot-tracked to your door. Those are expensive, regulated commitments - not the architecture of a vanishing act.

How the funnel treats you before money moves

A revealing test for any program that opens with a low first month: what happens before payment? HealthRx's assessment is free, takes about two minutes, and requires no payment to start - a clinician reviews your file before any charge, and nothing about the assessment obliges a purchase. Compare that against the industry's dark pattern of card-first funnels, and the sequencing here reads clean: medicine gates money, not the reverse.

What does HealthRx's price actually include?

The plan price covers more than most monthly plans do, which is part of the pitch:

IncludedThe detail
MedicationCompounded semaglutide, prepared per prescription ($39 first month, then $125/mo); tirzepatide $199/mo after the first month
Provider consultIndependent US-licensed clinician reviews your full history
ShippingOvernight, cold-chain, tracked - free on every plan
Dose adjustmentsPlan price does not change when your dose does
Ongoing check-insMessage the care team whenever something changes

No consultation fee, no shipping line at checkout, no insurance or prior authorization anywhere in the flow - it's cash-pay by design.

Prefer to see HealthRx for yourself before reading on? Open HealthRx's eligibility check → (opens HealthRx’s site)

What is the real risk with HealthRx's pricing?

The honest risk isn't fraud - the certifications above address that. It's fit: the monthly plan renews until canceled, and the lower rates on longer plans are not shown on its pages, so you cannot price a long commitment before signing. Most people tolerate GLP-1s well, but dose adjustments, side effects and life changes are real (see the semaglutide side-effects guide). A newer brand also means a shorter track record. Mitigations: the clinician gate can decline you before any charge, the free assessment costs nothing to run, and the monthly plan can be canceled by email. But what a longer plan costs is the one thing the pages do not say - ask before you prepay.

If the pros outweigh the cons for you, the intake is the next step. Start HealthRx's online intake → (opens HealthRx’s site)

What To Know Before Starting GLP-1 Treatment

Before starting GLP-1 treatment, it's important to understand a few key things. These medications require a prescription from a licensed clinician and aren't suitable for everyone. Some people may experience side effects, especially during the first few weeks as the body adjusts.

GLP-1s also tend to work best when combined with basic lifestyle habits like balanced nutrition and regular physical activity.

That's why choosing a provider that offers proper medical screening and ongoing follow-up support is essential for both safety and long-term success.

Woman preparing GLP-1 weight loss injection

Verdict: legitimate program, honest about its own catch

HealthRx checks out - LegitScript-certified, clinician-gated, 503A-fulfilled, with unusually clean pre-payment behavior and pricing that states its monthly plan in plain sight ($39 first month, then $125 a month for semaglutide), though the longer-plan tiers are not shown. It's built for the person who wants overnight logistics and a low first month. If you want the lowest monthly price, compare embody and welludr first.

→ Full HealthRx review: plans, process and fine print

→ The live matchup: HealthRx vs the trending Medvi

This article is general information, not medical advice.

Ready to compare weight loss providers?

See how top providers stack up on pricing, medical support, and treatment options.

Medical disclaimer

This page is general information about GLP-1 weight-loss medications such as semaglutide and tirzepatide, published to help you compare services. It is not medical advice, it does not create a doctor-patient relationship, and it is not a substitute for a consultation with a licensed clinician who knows your history. Treatments Hub is not a medical provider, pharmacy or clinic and does not prescribe, sell or dispense medication. Do not start, stop or change any treatment because of something you read here, and do not delay seeking care; in an emergency call 911.

Semaglutide and tirzepatide carry an FDA boxed warning about thyroid C-cell tumours seen in rodents and are not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, nor for use in pregnancy. Compounded versions sold by telehealth providers are prepared by state-licensed pharmacies and are not FDA-approved products. Where a review or post on this page mentions weight lost, that is one person's result and is not typical; results vary widely.

Medical and scientific statements on this site are checked against the sources linked on the page by our medical content reviewer, who does not choose providers or set prices. Prices, plans and customer reviews are each provider's published figures and customers' own words on the dates stated. We may earn a commission from provider links. The full medical and advertising disclaimer explains all of this in detail.

Sources & medical references

Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.

  1. 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
  2. 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
  3. 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
  4. 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
  5. 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
  6. 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
  7. 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)